SE8002475L - Syntetiska gener, serskilt influensagener, forfarande for deras framstellning, forfaranden och medel for anvendning av nemnda gener jemte dervid erhallna produkter - Google Patents

Syntetiska gener, serskilt influensagener, forfarande for deras framstellning, forfaranden och medel for anvendning av nemnda gener jemte dervid erhallna produkter

Info

Publication number
SE8002475L
SE8002475L SE8002475A SE8002475A SE8002475L SE 8002475 L SE8002475 L SE 8002475L SE 8002475 A SE8002475 A SE 8002475A SE 8002475 A SE8002475 A SE 8002475A SE 8002475 L SE8002475 L SE 8002475L
Authority
SE
Sweden
Prior art keywords
procedures
genes
production
agents
produce
Prior art date
Application number
SE8002475A
Other languages
English (en)
Swedish (sv)
Inventor
J S Emtage
N H Carey
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of SE8002475L publication Critical patent/SE8002475L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8002475A 1979-04-02 1980-03-31 Syntetiska gener, serskilt influensagener, forfarande for deras framstellning, forfaranden och medel for anvendning av nemnda gener jemte dervid erhallna produkter SE8002475L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7911487 1979-04-02

Publications (1)

Publication Number Publication Date
SE8002475L true SE8002475L (sv) 1980-10-03

Family

ID=10504279

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8002475A SE8002475L (sv) 1979-04-02 1980-03-31 Syntetiska gener, serskilt influensagener, forfarande for deras framstellning, forfaranden och medel for anvendning av nemnda gener jemte dervid erhallna produkter

Country Status (12)

Country Link
US (1) US4357421A (da)
JP (1) JPS562998A (da)
AU (1) AU5683680A (da)
BE (1) BE882545A (da)
DE (1) DE3012303A1 (da)
DK (1) DK142580A (da)
ES (1) ES490210A0 (da)
FR (1) FR2452924A1 (da)
GB (1) GB2049702B (da)
IT (1) IT1188920B (da)
NL (1) NL8001895A (da)
SE (1) SE8002475L (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK159976C (da) * 1979-06-01 1991-05-27 Searle & Co Plasmidvektorer, fremgangsmaade til fremstilling deraf, bakterieceller transformeret med plasmidvektorer samt udtrykkelse af protein i transformerede bakterieceller
EP0041313B1 (en) 1980-04-03 1990-09-12 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human fibroblast interferon
US4659669A (en) * 1981-03-02 1987-04-21 Regents Of The Univ. Of California Microbial expression of human influenza hemagglutinin proteins
DE3112338C2 (de) * 1981-03-28 1995-02-23 Klaus Von Der Helm Verwendung von Hybridisierungssonden zum Nachweis von HAV
EP0103632B1 (en) * 1982-03-15 1990-12-19 The Trustees Of Columbia University In The City Of New York Method for introducing cloned, amplifiable genes into eucaryotic cells and for producing proteinaceous products
US4870015A (en) * 1982-12-03 1989-09-26 Lubrizol Genetics, Inc. Method and composition for producing lectin in microorganisms
FR2540122B1 (fr) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
US4743553A (en) * 1984-07-18 1988-05-10 W. R. Grace & Co. Synthetic genes for bovine parainfluenza virus
AR241713A1 (es) 1984-08-30 1992-11-30 Smithkline Beckman Corp Molecula de dna con una secuencia de bases que codifica la proteina c13 y preparacion de vacunas contra la gripe.
US4631191A (en) * 1985-06-20 1986-12-23 Biotechnology Research Partners, Ltd. Methods and compositions useful in preventing equine influenza
DE3929144A1 (de) * 1989-09-02 1991-03-07 Behringwerke Ag Nachweis von influenza-a-virus durch polymerase-kettenreaktion (pcr) nach reverser transkription eines bereichs des viralen haemagglutinin-gens
US7049102B1 (en) 1989-09-22 2006-05-23 Board Of Trustees Of Leland Stanford University Multi-gene expression profile
CA2073630C (en) * 1991-08-30 2007-12-11 Atsushi Ohshima Method for synthesizing single-stranded stem-loop dnas, the products and uses therefor
ES2211878T3 (es) * 1991-08-30 2004-07-16 The University Of Medicine And Dentistry Of New Jersey Sobre-expresion de moleculas de adnn monocatenario.
DE4334467A1 (de) * 1993-10-08 1995-04-13 Rewo Chemische Werke Gmbh Verfahren zur Herstellung hochkonzentrierter fließfähiger wäßriger Lösungen von Betainen
US20070160581A1 (en) * 1994-04-29 2007-07-12 Cytogenix, Inc. Production of ssDNA in vivo
US6582938B1 (en) 2001-05-11 2003-06-24 Affymetrix, Inc. Amplification of nucleic acids
US20050175993A1 (en) * 2002-04-12 2005-08-11 Chia-Lin Wei Method for making full-length coding sequence cDNA libraries
US7504215B2 (en) 2002-07-12 2009-03-17 Affymetrix, Inc. Nucleic acid labeling methods
US20050003369A1 (en) * 2002-10-10 2005-01-06 Affymetrix, Inc. Method for depleting specific nucleic acids from a mixture
US8293684B2 (en) * 2006-11-29 2012-10-23 Exiqon Locked nucleic acid reagents for labelling nucleic acids
US20110059453A1 (en) * 2009-08-23 2011-03-10 Affymetrix, Inc. Poly(A) Tail Length Measurement by PCR

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK159976C (da) * 1979-06-01 1991-05-27 Searle & Co Plasmidvektorer, fremgangsmaade til fremstilling deraf, bakterieceller transformeret med plasmidvektorer samt udtrykkelse af protein i transformerede bakterieceller

Also Published As

Publication number Publication date
IT8048309A0 (it) 1980-04-01
DE3012303A1 (de) 1980-10-16
ES8105387A1 (es) 1981-05-16
IT1188920B (it) 1988-01-28
BE882545A (fr) 1980-09-30
AU5683680A (en) 1980-10-09
DK142580A (da) 1980-10-03
JPS562998A (en) 1981-01-13
NL8001895A (nl) 1980-10-06
ES490210A0 (es) 1981-05-16
GB2049702A (en) 1980-12-31
FR2452924A1 (fr) 1980-10-31
IT8048309A1 (it) 1981-10-01
GB2049702B (en) 1982-11-10
US4357421A (en) 1982-11-02

Similar Documents

Publication Publication Date Title
SE8002475L (sv) Syntetiska gener, serskilt influensagener, forfarande for deras framstellning, forfaranden och medel for anvendning av nemnda gener jemte dervid erhallna produkter
Uppada et al. Diagnosis and therapy with CRISPR advanced CRISPR based tools for point of care diagnostics and early therapies
ATE252110T1 (de) Markierte oligonukleotide
DE69636080D1 (de) Eine in Kaskaden verlaufende Vervielfältigungsreaktion von Nukleinsäuren
DE19812103A1 (de) Verfahren zur Synthese von Nucleinsäuremolekülen
ES2069598T3 (es) Metodo para fabricar oligonucleotidos que se unen especificamente a centros diana en moleculas de doble helice de adn, formando una triple helice colineal, los oligonucleotidos sinteticos y metodos de uso.
BR9106440A (pt) Oligonucleotideo ou analogo de olifonucleotideo e processo para tratar um animal suspeito de ter uma doenca que se caracteriza pela expressao de gene tat de hiv
DE502588T1 (de) Verfahren zur Amplifizierung von Nukleinsäuresequenzen.
FI3445388T3 (fi) Materiaaleja ja menetelmiä hemoglobinopatioiden hoitamiseksi
MX9706109A (es) Moleculas de adn, preparacion y utilizacion en terapia genica.
ATE172642T1 (de) Impfstoffe und verfahren zu ihrer herstellung
Griffin et al. Amplification of a specific region of the polyoma virus genome
AT352683B (de) Verfahren und vorrichtung zur herstellung von im wesentlichen wasserunloeslichen, ketten- foermigen ammoniumpolyphosphaten
CO2021014746A2 (es) Método para tratar distrofia muscular por direccionamiento del gen dmpk
Ling Pyrimidine Sequences from the DNA of Bacteriophages fd, fl, and ϕX174
Zhang et al. Chemical Modification and Transformation Strategies of Guide RNAs in CRISPR‐Cas9 Gene Editing Systems
AR018099A1 (es) Metodo de bloqueo de sintesis de la 17beta-hidroxiesteroide dehidrogenasa del tipo 5 y metodo para interferir su expresion
Deng et al. HIV infection detection using CRISPR/Cas systems: Present and future prospects
GB1049067A (en) Improvements in the production of micro-organisms from hydrocarbons
Williamson G-quartets in biology: reprise.
ES470340A1 (es) Un metodo para obtener una cepa de microorganismos modifica-dos para contener un fragmento de una secuencia especifica de desoxiribonucleotidos
Bhanot et al. A new system for studying molecular mechanisms of mutation by carcinogens.
Briand et al. Stucture of the amino-acid accepting 3'-end of high-molecular-weight eggplant mosaic virus RNA.
Thomas et al. Strand specificity of mutagenic bypass replication of DNA containing psoralen monoadducts in a human cell extract
DE19916417A1 (de) Amyloidspezifisches Aptamer

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8002475-5